Guidance for the gastrointestinal evaluation and management of iron deficiency in Sub-Saharan Africa
DOI:
https://doi.org/10.7196/SAMJ.2024.v114i1b.711Keywords:
Guidelines, Gastrointestinal, Evaluation, Management, Iron Deficiency, Iron Deficiency AnaemiaAbstract
Background. Over 30% of the world’s population is anaemic, with a significant proportion of these being iron deficient. As iron deficiency (ID) anaemia in men and post-menopausal women is mostly caused by gastrointestinal blood loss or malabsorption, the initial evaluation of a patient with ID anaemia involves referral to a gastroenterologist. The current drive towards patient blood management in sub-Saharan Africa (SSA)prescribes that we regulate not only the use of blood transfusion but also the management of patients in whom the cause of iron loss or inadequate iron absorption is sought. Recommendations have been developed to: (i) aid clinicians in the evaluation of suspected gastrointestinal iron loss and iron malabsorption, and often a combination of these; (ii) improve clinical outcomes for patients with gastrointestinal causes of ID; (iii) provide current, evidence-based, context-specific recommendations for use in the management of ID; and (iv) conserve resources by ensuring rational utilisation of blood and blood products.
Method. Development of the guidance document was facilitated by the Gastroenterology Foundation of Sub-Saharan Africa and the South African Gastroenterology Society. The consensus recommendations are based on a rigorous process involving 21 experts in gastroenterology and haematology in SSA. Following discussion of the scope and purpose of the guidance document among the experts, an initial review of the literature and existing guidelines was undertaken. Thereafter, draft recommendation statements were produced to fulfil the outlined purpose of the guidance document. These were reviewed in a round-table discussion and were subjected to two rounds of anonymised consensus voting by the full committee in an electronic Delphi exercise during 2022 using the online platform, Research Electronic Data Capture. Recommendations were modified by considering feedback from the previous round, and those reaching a consensus of over 80% were incorporated into the final document. Finally, 44 statements in the document were read and approved by all members of the working group.
Conclusion. The recommendations incorporate six areas, namely: general recommendations and practice, Helicobacter pylori, coeliac disease, suspected small bowel bleeding, inflammatory bowel disease, and preoperative care. Implementation of the recommendations is aimed at various levels from individual practitioners to healthcare institutions, departments and regional, district, provincial and national platforms. It is intended that the recommendations spur the development of centre-specific guidelines and that they are integrated with the relevant patient blood management protocols. Integration of the recommendations is intended to promote optimal evaluation and management of patients with ID, regardless of the presence of anaemia.
References
Kassebaum NJ. The global burden of anemia. Hematology/Oncology Clin North Am 2016;30(2):247- 308.
McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anae-mia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005. Public Health Nutr 2008;12(04):444.
Goddard AF, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. Gut 2000;46(90004):1iv-5.
Guidelines. The British Society of Gastroenterology Guidelines for the Management of iron deficiency anaemia. 2021. https://www.bsg.org.uk/wp-content/uploads/2021/09/Iron-Deficiency-Anaemia-in- Adults.pdf
CookJD.Themeasurementofserumtransferrinreceptor.AmJMedSci1999;318(4):269.
Bain BJ, Bates I, Laffan MA, Lewis SM. Dacie and Lewis. Practical Haematology. Mar-rickville,
Australia: Elsevier; 2017.
Jolobe OMP. Prevalence of hypochromia (without microcytosis) vs microcytosis (without
hypochromia) in iron deficiency. Clin Lab Haemat 2000;22(2):79-80.
Serum ferritin concentrations for the assessment of iron status in individuals and popula-tions:
Technical brief. World Health Organization. World Health Organization; 2011 (cited 13 November
. https://www.who.int/publications-detail-redirect/9789240008526
Rockey DC, Cello JP. Evaluation of the gastrointestinal tract in patients with iron defi-ciency anemia.
N Engl J Med 1993;329:1691-1695.
Cook IJ, Pavli P, Riley JW, et al. Gastrointestinal investigation of iron deficiency anae-mia. Br Med J
;292:1380-1382.
Zuckerman G, Benitez J. A prospective study of bidirectional endoscopy (colonoscopy and upper
endoscopy) in the evaluation of patients with occult gastrointestinal bleeding. Am J Gastroenterol
;87:62-66.
Hardwick RH, Armstrong CP. Synchronous upper and lower gastrointestinal endoscopy is an effective
method of investigating iron-deficiency anaemia. Br J Surg 1997;84:1725-1728.
JamesMW,ChenC-M,GoddardWP,etal.Riskfactorsforgastrointestinalmalignancyinpatientswith
iron-deficiency anaemia. Eur J Gastroenterol Hepatol 2005;17:1197-1203.
KepczykT,KadakiaSC.Prospectiveevaluationofgastrointestinaltractinpatientswithiron-deficiency
anemia. Dig Dis Sci 1995;40:1283-1289.
Ioannou GN, Scott K, Spector J, Rockey DC. Prospective evaluation of a clinical guide-line for the
diagnosis and management of iron deficiency anemia. Gastroenterology 2001;120(5).
McIntyre AS, Long RG. Prospective survey of investigations in outpatients referred with iron deficiency
anaemia. Gut 1993;34(8):1102-1107.
Coates A, Mountjoy M, Burr J. Incidence of iron deficiency and iron deficient anemia in elite runners and triathletes. Clin J Sport Med 2017;27:493-498.
Nayagam J, Ha S, Barreto L. PTU-120 iron deficiency anaemia in renal cell carcinoma. Gut 2018;67:A250-252.
Rockey DC, Altayar O, Falck-Ytter Y, et al. AGA technical review on gastrointestinal evaluation of iron deficiency anemia. Gastroenterology 2020;159:1097-1119.
Atkin W, Dadswell E, Wooldrage K, et al. Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): A multicentre randomised trial. Lancet 2013;381(9873):1194-202.
Halligan S, Altman DG, Taylor SA, et al. CT colonography in the detection of colorectal polyps and cancer: Systematic review, meta-analysis, and proposed minimum data set for study level reporting. Radiology 2005;237(3):893-904.
Tran-Duy A, Connell NJ, Vanmolkot FH, et al. Use of proton pump inhibitors and risk of iron deficiency: A population-based case-control study. J Internal Med 2018;285(2):205-214.
Xiaolu H, Xinhua Q, Weili Y, et al. Iron deficiency anaemia can be improved after eradi-cation of Helicobacter pylori. Postgrad Med J 201;86(1015):272-278.
Beyan C, Beyan E, Kaptan K, Ifran A, Uzar AÌ. Post-gastrectomy anemia: Evaluation of 72 cases with post- gastrectomy anemia. Hematology 2007;12(1):81-84.
Love AL, Billett HH. Obesity, bariatric surgery, and iron deficiency: True, true, true, and related. Am J Hematol 2008;83(5):403-409.
Smith S, Fowora M, Pellicano R. Infections with Helicobacter pylori and challenges en-countered in Africa. World J Gastroenterol 2019; 25(25): 3183-3195.
Hudak L, Jaraisy A, Haj S, Muhsen K. An updated systematic review and meta-analysis on the association between helicobacter pylori infection and iron deficiency anemia. Helico-bacter 2016;22(1).
Muhsen K, Cohen D. helicobacter pylori infection and Iron Stores: A systematic review and meta-analysis. Helicobacter 2008;13(5):323-340.
Bottaro G. The clinical pattern of subclinical/silent celiac disease: An analysis on 1026 consecutive cases. Am J Gastroenterology 1999;94(3):691-696.
Hoffbrand AV. Anaemia in adult coeliac disease. Clin Gastroenterol 1974;3(1):71-89.
Jones S, D’Souza C, Haboubi NY. Patterns of clinical presentation of adult coeliac disease in a rural setting.
Nutrition J 2006;5(1).
Fernández-Bañares F, Monzón H, Forné M. A short review of malabsorption and anemia. World J
Gastroenterol 2009;15(37):4644.
Harper JW, Holleran SF, Ramakrishnan R, Bhagat G, Green PHR. Anemia in celiac dis-ease is
multifactorial in etiology. Am J Hematol 2007;82(11):996-1000.
Bergamaschi G, Markopoulos K, Albertini R, et al. Anemia of chronic disease and defec-tive
erythropoietin production in patients with celiac disease. Haematologica 2008;93(12):1785-1791.
Green PHR. The many faces of celiac disease: Clinical presentation of celiac disease in the adult
population. Gastroenterology 2005;128(4).
Hopper AD, Cross SS, Hurlstone DP, et al. Pre-endoscopy serological testing for coeliac disease:
Evaluation of a clinical decision tool. BMJ 2007;334(7596):729.
Hill ID. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and
specificity vary in different populations? Gastroenterology 2005;128:S25-S32.
HopperAD,HadjivassiliouM,HurlstoneDP,etal.Whatistheroleofserologictestinginceliacdisease?A
prospective, biopsy-confirmed study with economic analysis. Clin Gas-troenterol Hepatol 2008;6:314-320.
Stone H, Almilaji O, John C, et al. The dedicated iron deficiency anaemia clinic: A 15-Year experience.
Front Gastroenterol 2020;13(1):20-24.
Sidhu PS, McAlindon ME, Drew K, Sidhu R. The utility of capsule endoscopy in patients under 50 years
of age with recurrent iron deficiency anaemia: Is the juice worth the squeeze? Gastroenterol Res Prac
;2015:1-5.
Carey EJ, Leighton JA, Heigh RI, et al. A single-center experience of 260 consecutive pa-tients undergoing
capsule endoscopy for obscure gastrointestinal bleeding. Am J Gastro-enterology 2007;102(1):89-95.
Shahidi NC, Ou G, Svarta S, et al. Factors associated with positive findings from capsule endoscopy in patients with obscure gastrointestinal bleeding. Clin Gastroenterol Hepatol 2012;10(12):1381-1385.
Xavier S, Magalhaes J, Rosa B, Moreira MJ, Cotter J. Impact of small bowel capsule endos-copy in
iron deficiency anemia: Influence of patient’s age on diagnostic yield. Arquivos de Gastroenterologia
;55(3):242-246.
Girelli CM, Soncini M, Rondonotti E. Implications of small-bowel transit time in the de-tection rate of
capsule endoscopy: A multivariable multicenter study of patients with ob-scure gastrointestinal bleeding.
World J Gastroenterology 2017;23(4):697.
Huprich JE, Fletcher JG, Fidler JL, et al. Prospective blinded comparison of wireless cap-sule endoscopy
and multiphase CT enterography in obscure gastrointestinal bleeding. Ra-diology 2011;260(3):744-751.
He B, Yang J, Xiao J, et al. Accuracy of computed tomographic enterography for obscure gastrointestinal
bleeding. Academic Radiology 2018;25(2):196-201.
Wang Z, Chen J-qiang, Liu J-lu, Qin X-gan, Huang Y. CT enterography in obscure gas-
trointestinal bleeding: A systematic review and meta-analysis. J Med Imaging Radiation Oncology
;57(3):263-273.
Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of
iron deficiency and anaemia in inflammatory bowel diseases. J Crohn’s Colitis 2015;9(3):211-222.
Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the
management of inflammatory bowel disease in adults. Gut 2019;68:s1-s106.
Kulnigg S, Gasche C. Systematic review: Managing anaemia in Crohn’s disease. Aliment Pharmacol Ther
;24(11-12):1507-1523.
Gargallo-Puyuelo CJ, Alfambra E, García-Erce JA, et al. Iron treatment may be difficult in inflammatory
diseases: Inflammatory bowel disease as a paradigm. Nutrients 2018;10(12):1959.
Aksan A, Wohlrath M, Iqbal TH, Dignass A, Stein J. Inflammation, but not the underly-ing disease or its location, predicts oral iron absorption capacity in patients with inflam-matory bowel disease. J Crohn’s
Colitis 2019;14(3):316-322.
Lindgren S, Wikman O, Befrits R, et al. Intravenous iron sucrose is superior to oral iron sulphate for
correcting anaemia and restoring iron stores in IBD patients: A randomised, controlled, evaluator-blind,
multicentre study. Scand J Gastroenterol 2009;44(7):838-845.
Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and
anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007;13(12):1545-1553.
Hou JK, Gasche C, Drazin NZ, et al. Assessment of gaps in care and the development of a care pathway for
anemia in patients with inflammatory bowel diseases. Inflamm Bowel Dis 2017;23(1):35-43.
Iqbal T, Stein J, Sharma N, Kulnigg-Dabsch S, Vel S, Gasche C. Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with in-flammatory bowel disease and iron
deficiency anemia. Digestive Dis Sci 2014;60(5):1375-1381.
Gasche C, Waldhoer T, Feichtenschlager T, et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. Am J Gastroenterol 2001;96:2382-2387.
Jimenez KM, Gasche C. Management of iron deficiency anaemia in inflammatory bowel disease. Acta Haematol 2019;142(1):30-36.
Kulnigg S, Teischinger L, Dejaco C, et al. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. Am J Gastro-enterol 2009;104(6):1460-1467. 60. Muñoz M, Acheson A, Auerbach M, et al. International consensus statement on the peri-operative
management of anaemia and iron deficiency. Anaesthesia 2017;72(2):233-247.
Kulnigg S, Stoinov S, Simanenkov V, et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: The ferric carboxymaltose (ferinject) randomised controlled trial. Am J
Gastroenterol 2008;103(5):1182-1192.
Mehta S, Sharma BS, Gulati S, et al. A prospective, randomised, interventional study of oral iron
supplementation comparing daily dose with alternate day regimen using hep-cidin as a biomarker in iron
deficiency anemia. J Assoc Physicians India 2020;68(5):39-41.
Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supple-ments given on
consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-
depleted women: Two open-label, randomised controlled trials. Lancet Haematol 2017;4(11):e524-e533. 64. Okam MM, Koch TA, Tran M-H. Iron supplementation, response in iron-deficiency anemia: Analysis of
five trials. Am J Med 2017;130(8).
Gurusamy KS, Richards T. Iron therapy in anaemic adults without chronic kidney disease. Cochrane
Database Sys Rev. 2013.
Kaundal R, Bhatia P, Jain A, et al. Randomised controlled trial of twice-daily versus alter-nate-day oral
iron therapy in the treatment of iron-deficiency anemia. Annals Hematol 2019;99(1):57-63.
Baird IM, Walters RL, Sutton DR. Absorption of slow-release iron and effects of ascorbic acid in normal
subjects and after partial gastrectomy. BMJ 1974;4(5943):505-508.
Cook JD, Reddy MB. Efficacy of weekly compared with daily iron supplementation. Am J Clin Nutr
;62(1):117-120.
Ahmad Fuzi SF, Koller D, Bruggraber S, Pereira DIA, Dainty JR, Mushtaq S. A 1-h time interval between
a meal containing iron and consumption of tea attenuates the inhibitory effects on iron absorption: A controlled trial in a cohort of healthy UK women using a stable Iron Isotope. Am J Clin Nutr 2017;106(6):1413-1421.
Li N, Zhao G, Wu W, et al. The efficacy and safety of vitamin C for iron supplementa-tion in adult patients with iron deficiency anemia. JAMA Network Open 2020;3(11).
Vyoral D, Jiri P. Therapeutic potential of hepcidin − the master regulator of iron metabo-lism. Pharmacological Res 2017;115:242-254.
Pasricha S-R, McHugh K, Drakesmith H. Regulation of hepcidin by erythropoiesis: The story so far. Ann Rev Nutrition 2016;36(1):417-434.
Moretti D, Goede JS, Zeder C, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood 2015;126(17):1981-1989.
Ekenved G. Absorption from different types of iron tablets - correlation between serum iron increase and total absorption of iron. Scand J Haematol 2009;17(S28):51-63.
TolkienZ,StecherL,ManderAP,PereiraDI,PowellJJ.Ferroussulfatesupplementationcausessignificant gastrointestinal side-effects in adults: A systematic review and meta-analysis. PLoS One 2015;10(2).
Frazer DM. A rapid decrease in the expression of DMT1 and Dcytb but not IREG1 or he-phaestin
explains the mucosal block phenomenon of iron absorption. Gut 2003;52(3):340-346.
StoffelNU,CercamondiCI,BrittenhamG,,etal.Ironabsorptionfromoralironsup-plementsgiven on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in
iron-depleted women: Two open-label, randomised controlled trials. Lancet Haematol 2017;4(11). 78. Reinisch W, Staun M, Tandon RK, et al. A randomised, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (monofer) compared with oral iron for treatment of anemia in
IBD (proceed). Am J Gastroenterol 2013;108(12):1877-1888.
Darwish AM, Khalifa EE, Rashad E, Farghally E. Total dose iron dextran infusion versus oral iron
for treating iron deficiency anemia in pregnant women: A randomised con-trolled trial. J Maternal-
Fetal Neonatal Med 2017;32(3):398-403.
BagerP,DahlerupJF.Randomisedclinicaltrial:Oralvs.intravenousironafteruppergas-trointestinal
haemorrhage - a placebo-controlled study. Aliment Pharmacol Therap 2013;39(2):176-187.
Xu Z, Qu H, Gong Z, et al. Risk factors for surgical site infection in patients undergoing colorectal
surgery: A meta-analysis of observational studies. PLoS One 2021;16(10):e0259107.
Gargallo-Puyuelo CJ, Alfambra E, García-Erce JA, Gomollon F. Iron treatment may be difficult in
inflammatory diseases: Inflammatory bowel disease as a paradigm. Nutrients 2018;10(12):1959.
Maas LA, Krishna M, Parian AM. Ironing it all out: A comprehensive review of iron defi-ciency
anemia in inflammatory bowel disease patients. Dig Dis Sci 2023;68(2):357-369.
Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastroin-testinal
bleeding. N Engl J Med 2013;368:11-21.
Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomised, controlled clinical trial of
transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators,
Canadian Critical Care Trials Group. N Engl J Med 199;340:409-417.
Bager P, Dahlerup JF. The healthcare cost of intravenous iron treatment in IBD patients depends on
the economic evaluation perspective. J Crohns Colitis 2010;4:427-430.
Garcia-Erce JA, Gomollon F, Munoz M. Blood transfusion for the treatment of acute anemia in
inflammatory bowel disease and other digestive diseases. World J Gastroenterol 2009;15:4686-4694. 88. Kiyatkin ME, Mladinov D, Jarzebowski ML, Warner MA. Patient blood management, anemia, and
transfusion optimisation across surgical specialties. Anesthesiol Clin 2023;41(1):161-174.
Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochimica et Biophysica Acta (BBA) -
Molecular Cell Research 2012;1823(9):1434-1443.
Van Wyck DB, Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT. Blood management: Large-
dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: A
randomised, controlled trial. Transfusion 2009;49(12):2719-2728.
Dickey S, Rockey DC. The natural history of iron deficiency anemia. Am J Med Sci 2019;358(5):357-362. 92. DeLoughery TG. Safety of oral and intravenous iron. Acta Haematologica 2019;142(1):8-12.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 W M Simmonds, Y Awuku, C Barrett, M Brand, K Davidson, D Epstein, E Fredericks, S Gabriel, S Grobler, C Gounden, L Katsidzira, V J Louw, V Naidoo, C Noel, E Ogutu, N Ramonate, N Seabi, M Setshedi, J Van Zyl, G Watermeyer, C Kassianides
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
